Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist

Abstract

Varenicline tartrate demonstrated both short-term (1 mg twice daily and 1 mg once daily) and long-term efficacy (1 mg twice daily) vs placebo. Varenicline was well tolerated and may provide a novel therapy to aid smoking cessation.